Calorie Restriction as a Protective Strategy for Retinal Cells
Interview of Professor Benedetto Falsini and Professor Andrea Cosumano
Thursday, 23rd June 2022, at Press Room of the Chamber of Deputies, Rome
On June 23rd 2022, an important event for the presentation of the innovative spin-off, MagisNat, American branch of MAGI group, will be held at the Press Room of the Italian Chamber of Deputies in Rome from 04:00 p.m. to 06:00 p.m.
On this occasion, professors and researchers both from Italy and the United States (especially from the city of Atlanta) will meet to discuss extremely important issues, such as: the importance of proper nutrition in this hasty era, in which people consume fast food daily; the spread of the Mediterranean diet as a powerful tool to teach people how to eat in a healthy and balanced way; the studies on natural molecules, aiming at finding effective and non-invasive treatments against the diseases researched by MAGI Laboratories, such as obesity, anorexia, lymphedema, and lipedema; the promotion of supplements based on natural molecules, whose properties are studied by researchers of MAGI group in order to solve nutrient deficiencies.
The event will be attended by Professor Benedetto Falsini, from the Institute of Ophthalmology at Università Cattolica del Sacro Cuore (Rome, Italy) and Professor Andrea Cosumano, President of the Macula & Genoma Foundation USA (New York, USA): they will hold a presentation entitled “Calorie Restriction as a Protective Strategy for Retinal Cells”, a very delicate and innovative topic.
In particular, they will discuss the importance of a healthy and proper diet in order to protect the retinal cells and to prevent the occurrence of particular retinal pathologies. Many studies, carried out both by the two professors and by other researchers, have shown that there is a biochemical link between calorie restriction and retinal cells in humans. It emerged that the adoption of a healthy diet—balanced in micronutrients and low in fats—leads to the activation of genes that have a neuroprotective function for the retinal cells. Given the results obtained so far, the research conducted by Professor Falsini and Professor Cosumano could lead to positive developments in the medical field, particularly in the neuroprotective field.
On this occasion, professors and researchers both from Italy and the United States (especially from the city of Atlanta) will meet to discuss extremely important issues, such as: the importance of proper nutrition in this hasty era, in which people consume fast food daily; the spread of the Mediterranean diet as a powerful tool to teach people how to eat in a healthy and balanced way; the studies on natural molecules, aiming at finding effective and non-invasive treatments against the diseases researched by MAGI Laboratories, such as obesity, anorexia, lymphedema, and lipedema; the promotion of supplements based on natural molecules, whose properties are studied by researchers of MAGI group in order to solve nutrient deficiencies.
The event will be attended by Professor Benedetto Falsini, from the Institute of Ophthalmology at Università Cattolica del Sacro Cuore (Rome, Italy) and Professor Andrea Cosumano, President of the Macula & Genoma Foundation USA (New York, USA): they will hold a presentation entitled “Calorie Restriction as a Protective Strategy for Retinal Cells”, a very delicate and innovative topic.
In particular, they will discuss the importance of a healthy and proper diet in order to protect the retinal cells and to prevent the occurrence of particular retinal pathologies. Many studies, carried out both by the two professors and by other researchers, have shown that there is a biochemical link between calorie restriction and retinal cells in humans. It emerged that the adoption of a healthy diet—balanced in micronutrients and low in fats—leads to the activation of genes that have a neuroprotective function for the retinal cells. Given the results obtained so far, the research conducted by Professor Falsini and Professor Cosumano could lead to positive developments in the medical field, particularly in the neuroprotective field.